Phil Parkinson can have few concerns after the start Wrexham have made to life in League One, but the manager is especially pleased with the strength in depth running through his squad this campaign.

Wrexham boss Phil Parkinson says Marriott has suffered a broken fibula, but hopes the 30-year old can return to play a part for the Welsh club this season. A 1-0 win at Rotherham means Wrexham ...

AbbVie (NYSE: NYSE:ABBV) today announced the FDA approval of VYALEV™, the first subcutaneous 24-hour continuous infusion therapy for adults with advanced Parkinson's disease. This new treatment ...

AbbVie Inc. said Thursday the Food and Drug Administration has approved its vyalev as the first and only subcutaneous 24-hour continuous ... fluctuations in advanced Parkinson’s disease.

as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations in adults with advanced Parkinson’s disease (PD). The approval was supported by the pivotal ...

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV) today announced the FDA approval of VYALEV™, the first subcutaneous 24-hour continuous infusion therapy for adults with advanced Parkinson's disease.

The first levodopa-based treatment for motor fluctuations in people with advanced Parkinson's disease, VYALEVa subcutaneous 24-hour continuous infusion of foscarbidopa and foslevodopais now ...

A retired nurse has said a new drug therapy for Parkinson's disease has given her ... bloodstream using a pump via a portable kit worn 24 hours a day. Ms Fuller began using the treatment at ...

Wrexham have won six of their 10 League Two games so far this season Wrexham manager Phil Parkinson says his players are "recharged" after the international break - even though they were keen to ...

A retired nurse has said a new drug therapy for Parkinson's disease has given her "a chance at ... which are steadily released into the bloodstream using a pump via a portable kit worn 24 hours a day.